There is a tide in the affairs of men, which taken at the flood leads to fortune. Omitted all the voyage of their life, Is bound in shallows and in miseries. On such a full sea are we now afloat; And we must take the current when it serves Or lose our …
Roche Holding AG (OTCQX:RHHBY) Q1 2019 Results Earnings Conference Call April 17, 2019 8:00 AM ET Company Participants Severin Schwan - CEO, Roche Group Bill Anderson - CEO, Roche Pharmaceuticals Michael Heuer - CEO Roche Diagnostics Alan Hippe - Chief …
Fresh from having gained the first checkpoint inhibitor approval in triple negative breast cancer (TNBC) with Tecentriq, Roche has presented phase 1b data of a new combination that could further boost results in these patients. The results of its …
DALLAS--(BUSINESS WIRE)--Mar 11, 2019--Susan G. Komen®, the world’s leading breast cancer organization, announced today a new effort to better understand and address why certain populations of breast cancer patients have different outcomes, including why …
SUMMIT, N.J.--(BUSINESS WIRE)--Mar 12, 2019--Celgene Corporation (NASDAQ: CELG) today announced two updates for ABRAXANE ® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in the treatment of metastatic triple-negative breast …
MONDAY, March 11, 2019 -- The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) was given accelerated approval for triple- …
The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) was given accelerated approval for triple-negative breast cancer …
× FDA signs off on new breast cancer treatment The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The treatment received accelerated approval for triple-negative …
The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and …
The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and …
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 8, 2019--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq ® (atezolizumab) plus …
FDA Approves Herceptin Hylecta for Subcutaneous Injection in Certain HER2-Positive Breast Cancers South San Francisco, CA -- February 28, 2019 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug …
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 18, 2019--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab), in combination with …
Scripps Florida scientist Matthew Disney and his research team in Jupiter have developed a compound that could help make breast cancer patients more receptive to treatment. There are drugs that have been shown to be effective with fast-growing breast …
Ms. Walker is expanding breast and ovarian cancer awareness to African-American and Caribbean women in the five boroughs through NYC nonprofit SHARE This press release was orginally distributed by ReleaseWire New York, NY -- (ReleaseWire) -- 02/05/ …
- Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes - Kadcyla was granted Breakthrough Therapy Designation for this application Basel -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today …
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 5, 2019--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced completing the submission of a supplemental Biologics License Application to the U.S. Food and Drug …
Genentech, a member of the Roche Group (ROG.SW,RO.SW), announced completing the submission of a supplemental Biologics License Application to the U.S. FDA for Kadcyla for after surgery treatment of people with HER2-positive early breast cancer with …
Clinically Meaningful and Statistically Significant Decrease in the Frequency of Clinically Detected Recurrences in the TNBC Cohort Treated with Nelipepimut-S plus Trastuzumab (p=0.004) Specific Benefit in Four Predefined Subgroups of TNBC Patients …
Oncology specialist Dr. Eugenio Galindo provides professional insight into common breast cancer risk factors in the United States. MISSION, TEXAS, USA, April 16, 2019 /EINPresswire.com/ -- Cancer which forms in the cells of the breasts, breast …
WESTPORT, Conn., April 17, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary therapeutic agents, …
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
Have an event? Add it to our Events & Conferences Directory.
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/21/2019
JURAVIN RESEARCH found "natural" or "fresh" orange juice to be very fattening, with NO HEALTH BENEFITS, and an expensive price: 250% more than other drinks. ORLANDO, FLORIDA, UNITED STATES, April 19, 2019 /EINPresswire.com/ …
SEATTLE, WASHINGTON, USA, April 19, 2019 /EINPresswire.com/ -- For decades, Dr. Gregory Jantz has studied hundreds of patient disorders to help them arrive at a healthy resolution using his unique approach to care. Through whole-person care, …
Specialist behavioral expert Rocio Moustafa takes a closer look at the condition known as antisocial personality disorder. VENTURA, CALIFORNIA, USA, April 19, 2019 /EINPresswire.com/ -- With more than 200,000 cases diagnosed in the United States …
Healthcare mergers are becoming ever more popular. Himachal Mukhopadhyay discusses some of the top mergers of 2018. ROSEVILLE, CALIFORNIA, USA, April 19, 2019 /EINPresswire.com/ -- While we might one quarter of the way through the new year …
Urology specialist Cletus Roy Georges, MD reveals more about stress urinary incontinence and the associated condition known as 'overactive bladder.' ORLANDO, FLORIDA, USA, April 19, 2019 /EINPresswire.com/ -- Stress urinary …
NaVOBA and the NBIC share symbiotic goals to advocate for the business interests of a diverse range of people in Corporate America's inclusion initiatives. PITTSBURGH, PA, USA, April 19, 2019 /EINPresswire.com/ -- ECONOMIC NEWS: Veteran …
The Diabetes Care Devices Market from The Business Research Company, offers a sales Strategies, growth analysis, size, segmentation, forecast and much more. LONDON, GREATER LONDON, UK, April 19, 2019 /EINPresswire.com/ -- The market for diabetes …
SC RegenCare now offering state-of-the-art ESWT to treat ED CHARLESTON, SC, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- ESWT (Extracorporeal Smart Wave Therapy) uses energy from acoustic sound waves to stimulate blood vessel growth …
Veterinary Pharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Veterinary Pharmaceuticals Industry Description Wiseguyreports. …
CONROE, TEXAS, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- Every day a new threat to your health and safety is announced in the media--like the recall of turkey products tainted by salmonella, a new strain of antibiotic resistant bacteria …
MORRISVILLE, VERMONT, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- The ancient art of Palmistry dates back to ancient Greece and Aristotle and was widely used throughout empires and nations. Today many of us battle with relationship …
Pharma Excipients -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Pharma Excipients Industry Description Wiseguyreports.Com Adds “Pharma …
Superabrasives -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Superabrasives Industry Description Wiseguyreports.Com Adds “Superabrasives …
Energy Nutrition Bars -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Energy Nutrition Bars Industry Description Wiseguyreports.Com Adds “ …
The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, is …
Santhigram Kerala Ayurveda opens its Premium Ayurvedic Hospital at Gurugram, NCR Delhi, India NEW DELHI, DELHI, INDIA, April 19, 2019 /EINPresswire.com/ -- Santhigram Kerala Ayurveda opens its Premium Ayurvedic Hospital at Gurugram, NCR Delhi, …
ITFirms goes for balance in its hunt for top e-commerce development companies'19! NEW YORK, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- According to Michael Leboeuf, a satisfied customer is the best business strategy of all. Success …
FORT COLLINS, Colo., April 19, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully leveraged a robust intellectual property portfolio by applying patented drug delivery system technologies to cannabinoid formulations …
Download logo Three IRC staff caught up in attack that led to tragic loss of life of an Ebola Response staff member; IRC stands with the community and sister organizations in mourning this attack; To date more than 1,290 people have contracted Ebola since …
The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose. The agency is also …
Welcome to EIN Newsdesk
Millions of professionals find us an indispensable source for
breaking news. Basic accounts are FREE.
Sources
We scan thousands of news sites, so you don't have to, saving
you time and money.
Topics
We are similar to Google News but focus on news tracking by country,
industry and topic, so you don't miss any important news
that affects your company, organization or interest.
Custom News
Any news page or search results can be turned into an email news alert
or live RSS feed. You can share relevant news on your website,
intranet, workgroup or mobile device.
News Alert Maker
It's a one-stop destination for all your alerts and feeds.
Manage your media monitoring in one secure location.
Relevant. Time-Saving. Free.
And so easy to use. Check out our short video and
check in with us to start right now.
Get Started
Join millions of professionals in business, industry, and government who
have relied on EIN News since 1995.
